K-numberK243642
Device nameUltraCor™ Twirl™ Breast Tissue Marker
ApplicantBard Peripheral Vascular, Inc.
Product codeNEU
Device classClass II
Decision dateMar 24, 2025
DecisionSubstantially Equivalent
Regulation878.4300
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The UltraCor™ Twirl™ Breast Tissue Marker (Curls and Clover) is a disposable beveled needle applicator containing a Nitinol radiographic marker designed for long-term marking of breast tissue biopsy sites. The marker is deployed from a 17-gauge needle tip into soft breast tissue, including axillary lymph nodes, to enable radiographic localization during subsequent clinical procedures.

Technological characteristics

The subject device is substantially equivalent to the predicate (Ring shape marker, K180061) in intended use, indications, performance characteristics, target population, fundamental scientific technology, operating principle, Nitinol wireform material, sterilization method, shelf-life, and packaging. The devices differ only in marker shapes (Curls and Clover versus Ring) and applicator handle overmold colorants.

Test standards cited

Not stated in this summary. The document references FDA Guidance on Design Control (March 11, 1997) but does not cite specific consensus standards (ISO, IEC, ASTM, etc.).

Substantial equivalence argument

The subject device performs identical clinical functions to the predicate using the same fundamental technology, materials, sterilization, and deployment mechanism. Comprehensive biocompatibility testing (cytotoxicity, sensitization, irritation, acute toxicity, subchronic toxicity, genotoxicity, implantation studies) and performance testing (visibility, retention, deployment accuracy and force, corrosion resistance) demonstrate the Curls and Clover marker shapes perform as safely and effectively as the Ring shape predicate. The only differences—cosmetic marker shapes and handle colorants—do not affect the device's safety or effectiveness in radiographic marking.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →